Implementation of Ask-Advise-Connect in a safety net healthcare system: quitline treatment engagement and smoking cessation outcomes.

Ask-Advise-Connect Implementation Phone counseling Quitline Smoking cessation Treatment engagement

Journal

Translational behavioral medicine
ISSN: 1613-9860
Titre abrégé: Transl Behav Med
Pays: England
ID NLM: 101554668

Informations de publication

Date de publication:
03 02 2020
Historique:
pubmed: 27 11 2018
medline: 19 8 2021
entrez: 27 11 2018
Statut: ppublish

Résumé

Ask-Advise-Connect (AAC) was designed to link smokers in primary care settings with evidence-based tobacco treatment delivered via state quitlines. AAC involves training medical staff to Ask about smoking status, Advise smokers to quit, and offer to immediately Connect smokers with quitlines through an automated link within the electronic health record. We evaluated the efficacy of AAC in facilitating treatment engagement and smoking abstinence in a 34 month implementation trial conducted in a large, safety-net health care system. AAC was implemented from April 2013 through February 2016 in 13 community clinics that provided care to low-income, predominantly racial/ethnic minority smokers. Licensed vocational nurses were trained to implement AAC as part of standard care. Outcomes included (a) treatment engagement (i.e., proportion of identified smokers that enrolled in treatment) and (b) self-reported and biochemically confirmed abstinence at 6 months. Smoking status was recorded for 218,915 unique patients, and 40,888 reported current smoking. The proportion of all identified smokers who enrolled in treatment was 11.8%. Self-reported abstinence at 6 months was 16.6%, and biochemically confirmed abstinence was 4.5%. AAC was successfully implemented as part of standard care. Treatment engagement was high compared with rates of engagement for more traditional referral-based approaches reported in the literature. Although self-reported abstinence was in line with other quitline-delivered treatment studies, biochemically confirmed abstinence, which is not routinely captured in quitline studies, was dramatically lower. This discrepancy challenges the adequacy of self-report for large, population-based studies. A more detailed and comprehensive investigation is warranted.

Identifiants

pubmed: 30476236
pii: 5198988
doi: 10.1093/tbm/iby108
pmc: PMC7295694
doi:

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

163-167

Subventions

Organisme : NIDA NIH HHS
ID : K23 DA040933
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA225520
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM104938
Pays : United States

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the Society of Behavioral Medicine.

Références

Addiction. 2008 Sep;103(9):1553-61
pubmed: 18783507
MMWR Morb Mortal Wkly Rep. 2017 Nov 10;66(44):1209-1215
pubmed: 29121001
BMC Fam Pract. 2009 Dec 17;10:81
pubmed: 20017930
Am J Prev Med. 2010 Apr;38(4):367-74
pubmed: 20307804
BMC Fam Pract. 2008 Mar 28;9:18
pubmed: 18373854
Psychol Bull. 1992 Jan;111(1):23-41
pubmed: 1539088
Transl Behav Med. 2017 Jun;7(2):148-156
pubmed: 27800564
Tob Control. 2007 Dec;16 Suppl 1:i9-15
pubmed: 18048639
JAMA Intern Med. 2013 Mar 25;173(6):458-64
pubmed: 23440173
Am J Public Health. 1994 Jul;84(7):1086-93
pubmed: 8017530
Am J Prev Med. 2013 Dec;45(6):737-41
pubmed: 24237916
Addiction. 2017 Dec;112(12):2227-2236
pubmed: 28834608
Drug Alcohol Rev. 2006 Jan;25(1):73-8
pubmed: 16492579
Am Psychol. 2010 May-Jun;65(4):252-61
pubmed: 20455619
Am J Med Sci. 2003 Oct;326(4):201-5
pubmed: 14557735
Cochrane Database Syst Rev. 2013 Aug 12;(8):CD002850
pubmed: 23934971
Transl Behav Med. 2014 Sep;4(3):324-32
pubmed: 25264471
Nicotine Tob Res. 2002 May;4(2):149-59
pubmed: 12028847

Auteurs

Bárbara Piñeiro (B)

Oklahoma Tobacco Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Damon J Vidrine (DJ)

Oklahoma Tobacco Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

David W Wetter (DW)

Huntsman Cancer Institute and the Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.

Diana S Hoover (DS)

Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Summer G Frank-Pearce (SG)

Oklahoma Tobacco Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Nga Nguyen (N)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Susan M Zbikowski (SM)

InZights Consulting, Seattle, WA, USA.

Jennifer I Vidrine (JI)

Oklahoma Tobacco Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Department of Family and Preventive Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH